Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00502398|
Recruitment Status : Unknown
Verified October 2007 by Rabin Medical Center.
Recruitment status was: Recruiting
First Posted : July 17, 2007
Last Update Posted : October 16, 2007
Patients with hemolytic disorders (e.g. sickle cell anemia or thalassemia) are known to develop pulmonary hypertension. Hemolysis is where red blood cells are destroyed and their contents released into the circulation. It is thought that these red-cell contents cause constriction and thrombosis of the blood vessels in the lungs. Conversely, it is possible that patients with pulmonary hypertension have hemolysis.
In this study we will be drawing blood from a range of patients and normal controls for a panel of blood tests related to hemolysis.
|Condition or disease||Intervention/treatment|
|Pulmonary Artery Hypertension||Procedure: Blood test|
|Study Type :||Observational|
|Study Start Date :||September 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00502398
|Contact: Ben Fox, MRCP||+972 3 937 firstname.lastname@example.org|
|Pulmonary Institute, Rabin Medical Center (Beilinson campus)||Recruiting|
|Petach Tikva, Israel, 49100|
|Contact: Ben Fox, MRCP email@example.com|
|Principal Investigator:||Mordechai Kramer, MD||Rabin Medical Center|